FdaApplication
ANDA 212231
Identifiers
- fda_app_no: ANDA212231
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2019-06-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLE; TRIMETHOPRIM | 80MG/ML;16MG/ML | INJECTABLE;INJECTION |
1 product